Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-02-23

FDA Approved: PYRIDOSTIGMINE BROMIDE — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for pyridostigmine bromide by Oceanside Pharmaceuticals (brand Mestinon).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mestinon (pyridostigmine bromide)

Snippet

SUPPL AP for PYRIDOSTIGMINE BROMIDE (PYRIDOSTIGMINE BROMIDE)